High Tide Inc. is trying to turn cannabis retail into Costco (and Germany is the next aisle)
Date Published

TL;DR
Quick Summary
- High Tide reported fiscal Q4 2025 results on January 29, 2026, with record revenue of $164.0M and record adjusted EBITDA of $12.4M for the quarter.
- Its Canna Cabana loyalty strategy keeps scaling: 2.5M+ Canadian members and 151K+ paid ELITE members as of fiscal year-end October 31, 2025.
- Germany is the new chapter: High Tide closed its majority stake in Remexian, but flagged near-term margin pressure tied to European inventory cleanup.
#RealTalk
High Tide is trying to win cannabis by acting like a retailer first and a hype story never. The upside is consistency; the risk is that Europe adds complexity faster than it adds clean profits.
Bottom Line
This stock is increasingly a bet on retail execution and loyalty economics—plus a careful expansion into Germany’s medical market—rather than a single regulatory catalyst. The key investor watchpoints are whether free cash flow stays positive as it scales, and whether the Germany distribution business stabilizes margins after early integration noise.
What High Tide’s quarter really says
Cannabis stocks have a reputation for drama: big promises, regulatory limbo, and charts that can ruin a perfectly good mood. High Tide Inc. (HITI) is trying to be the opposite kind of story. Less “moonshot,” more “repeat customer.” And its latest results make a case that boring—when it’s disciplined—can be a flex.
On January 29, 2026, High Tide reported fiscal Q4 2025 and full-year results (for the period ending October 31, 2025) featuring record quarterly revenue of $164.0 million and record adjusted EBITDA of $12.4 million in the quarter. It also stayed free-cash-flow positive for the full fiscal year, even while expanding and writing a meaningful check to enter Europe.
If you’ve been conditioned to think cannabis companies only come in two flavors—“pre-revenue dreams” or “post-hype hangovers”—High Tide is angling for a third: retail operator with a loyalty engine.
Canna Cabana: the loyalty program is the product
High Tide’s core identity is Canna Cabana, its Canadian retail chain. The company said it ended calendar 2025 as Canada’s largest cannabis retailer with 218 stores, after opening 27 new locations organically during the year.
But stores are the visible part. The less obvious part is the membership flywheel.
High Tide said Canadian Cabana Club membership now exceeds 2.5 million (up 45% year over year), and its paid ELITE tier in Canada surpassed 151,000 members (up 107% year over year). Globally, Cabana Club membership passed 6.56 million, with 160,400 ELITE members.
That matters because cannabis retail has become brutally competitive: pricing pressure, lots of lookalike shops, and customers who will absolutely switch for a better deal. In that kind of market, loyalty isn’t a cute marketing add-on—it’s the moat. High Tide’s “discount club” framing is basically: come for the low price, stay because you feel like an insider.
In fiscal 2025, High Tide reported same-store sales up 4.1%, and Q4 same-store sales up 5.5% year over year. That’s not viral-growth territory, but in a mature retail category, it’s a signal that the model is still pulling.
Germany: a new market, a new set of risks
The bigger narrative shift is Europe—specifically Germany.
High Tide announced on August 14, 2025 that it would acquire a 51% stake in Remexian Pharma GmbH to become a major importer and distributor of medical cannabis flower into Germany. By January 29, 2026, it said the majority stake acquisition had closed.
Remexian adds a different kind of business to High Tide: distribution, not storefront retail. High Tide also acknowledged a Q4 gross margin headwind tied to the new medical cannabis distribution segment, pointing to older biomass in Portugal being liquidated at lower prices due to limited time to expiry. Translation: the European expansion comes with messy, unglamorous inventory realities.
Also notable: despite the operational progress, High Tide reported a Q4 net loss of $46.7 million, which it attributed to two one-time items (including a non-cash impairment and fair value changes in derivative liabilities). Adjusted for those, it said Q4 net income would have been $1.4 million, or $0.02 per fully diluted share.
Why this matters if you’re not trying to “trade cannabis”
High Tide is quietly pitching a thesis that’s easier to underwrite than “federal legalization is coming any minute now.” It’s betting that scale plus loyalty plus retail execution can produce something cannabis investing rarely delivers: repeatable performance.
For investors watching cannabis through broad baskets like the ETFs MJ and YOLO, High Tide is one of the names that can matter because it’s tied to operational retail metrics—not just headlines.
The real question going forward isn’t whether High Tide can open more stores. It’s whether it can keep turning membership into pricing power, and whether Germany becomes a growth lane without diluting the discipline that made the Canadian model work.